dihexa safety human trials EllieMD Dihexa · Disguised Alpha

TB-500 (Thymosin Beta-4) Phase I and Phase II safety trials of intravenous thymosin beta-4 published in human cohorts (Ruff et al., 2010)

There was also significant suppression of angiogenesis and myofibroblast recruitment

Several aspects related to their metabolism and mechanisms of body damage are not fully known

While preliminary studies suggest Dihexa is generally safe with minimal adverse reactions, it's important to note that long-term clinical data is limited

Directed share programs allow underwriters and issuing companies to direct a percentage of shares to affiliates

Some patients develop a sore, red tongue (glossitis) or mouth ulcers